Tetraploid cells primarily support the extraembryonic component, whereas introduced embryonic stem or induced pluripotent stem cells contribute to the embryo proper. This division lets investigators assess whether the donor population can supply the cells needed for embryonic development rather than merely participating in a mixed cell population. The resulting lineage separation is central to interpreting complementation experiments.
The assay places a demanding developmental requirement on the donor cells: they must generate the embryo proper within an embryo whose tetraploid cells mainly form extraembryonic tissues. Consequently, complementation provides stronger evidence of developmental potential than an assessment limited to selected cell types or isolated differentiation outcomes. It is therefore used to evaluate the functional capacity of pluripotent stem-cell lines.
Conversion changes the expected contribution of the embryo’s own cells, making tetraploid cells primarily associated with extraembryonic tissues. This creates a developmental setting in which the introduced pluripotent cells can be examined for their contribution to the embryo proper. The altered cellular arrangement is what allows the assay to distinguish donor-cell developmental capacity from the supporting role of tetraploid cells.
Electrofusion is commonly performed at the two-cell stage to convert diploid embryos into tetraploid embryos. The resulting embryos are then used to produce blastocysts, into which pluripotent embryonic stem or induced pluripotent stem cells are introduced. Maintaining this sequence is important because the assay depends on establishing the tetraploid embryo before evaluating donor-cell contributions.
A typical workflow begins with diploid embryos, followed by electrofusion at the two-cell stage to generate tetraploid embryos. These embryos develop into blastocysts, and pluripotent embryonic stem or induced pluripotent stem cells are introduced into them. Researchers then evaluate whether the donor cells contribute to the embryo proper, using that outcome to assess developmental potential.
Tetraploid embryo complementation supports several related investigations: evaluating stem-cell pluripotency, dissecting contributions to distinct cell lineages, and studying early mammalian development. Because tetraploid and donor cells have different developmental contributions, the assay can connect a stem-cell population with its capacity to participate in embryonic formation. Its use is especially relevant when a stringent functional test is required.
The method is technically demanding, and complementation is inefficient. These limitations make it unsuitable for routine use despite the strength of its developmental readout. Experimental interpretation therefore depends on recognizing that an unsuccessful or infrequent complementation event may reflect procedural constraints as well as the developmental properties of the tested embryonic or induced pluripotent stem-cell population.